Root Financial Partners’s Immunovant IMVT Stock Holding History

Root Financial Partners’s Portfolio IMVT Stock Details IMVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$169	Buy	+5	New	+$197	﹤0.01%	3550

Other funds holding IMVT

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Root Financial Partners's IMVT Position: Q3 2026 in Review

Root Financial Partners opened a new position in Immunovant (IMVT) in Q3 2026: 5 shares worth $169. The stake represents ﹤0.01% of the portfolio and ranks #3550 among its holdings.

101 funds tracked by Wall St. Rank hold IMVT as of Q3 2026.

Root Financial Partners held 5 shares of Immunovant worth $169 as of Q3 2026.
Immunovant was a new Root Financial Partners position in Q3 2026.
Immunovant made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #3550 holding.
101 funds tracked by Wall St. Rank held Immunovant as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.